Bemiparin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 31: | Line 31: | ||
'''Bemiparin''' is an antithrombotic and belongs to the group of [[low molecular weight heparin]]s (LMWH).<ref>{{cite journal |author=Chapman TM, Goa KL |title=Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis |journal=Drugs |volume=63 |issue=21 |pages=2357–77 |year=2003 |pmid=14524738 |doi=10.2165/00003495-200363210-00009}}</ref> | '''Bemiparin''' is an antithrombotic and belongs to the group of [[low molecular weight heparin]]s (LMWH).<ref>{{cite journal |author=Chapman TM, Goa KL |title=Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis |journal=Drugs |volume=63 |issue=21 |pages=2357–77 |year=2003 |pmid=14524738 |doi=10.2165/00003495-200363210-00009}}</ref> | ||
Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low [[molecular mass]] of 3600 [[Dalton (unit)|Daltons]] on average. | Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low [[molecular mass]] of 3600 [[Dalton (unit)|Daltons]] on average. ([[Enoxaparin]] has 4500 Daltons.) These heparins have lower anti-[[thrombin]] activity than classical LMWHs and act mainly on [[factor Xa]], reducing the risk of bleeding. | ||
==External Links== | ==External Links== | ||
Latest revision as of 00:56, 26 July 2014
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
|
WikiDoc Resources for Bemiparin |
|
Articles |
|---|
|
Most recent articles on Bemiparin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bemiparin at Clinical Trials.gov Clinical Trials on Bemiparin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bemiparin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bemiparin Discussion groups on Bemiparin Directions to Hospitals Treating Bemiparin Risk calculators and risk factors for Bemiparin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bemiparin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bemiparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).[1]
Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low molecular mass of 3600 Daltons on average. (Enoxaparin has 4500 Daltons.) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.
External Links
- Chapman TM, Goa KL (2003). "Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis". Drugs. 63 (21): 2357–77. PMID 14524738.
- bemiparin at the US National Library of Medicine Medical Subject Headings (MeSH)
References
- ↑ Chapman TM, Goa KL (2003). "Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis". Drugs. 63 (21): 2357–77. doi:10.2165/00003495-200363210-00009. PMID 14524738.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Anticoagulants